User:Mr. Ibrahem/Quetiapine

From Wikipedia, the free encyclopedia
Mr. Ibrahem/Quetiapine
Clinical data
Pronunciation/kwɪˈtaɪ.əpiːn/ kwi-TY-ə-peen
Trade namesSeroquel, Temprolide, others
AHFS/Drugs.comMonograph
MedlinePlusa698019
License data
Pregnancy
category
  • AU: B3
Routes of
administration		By mouth
Drug classAtypical antipsychotic[1]
Legal status
Legal status
Pharmacokinetic data
Bioavailability100%[2]
Protein binding83%[3]
MetabolismLiver via CYP3A4-catalysed sulfoxidation to its active metabolite norquetiapine (N-desalkylquetiapine)[6]
Elimination half-life7 hours (parent compound); 9–12 hours (active metabolite, norquetiapine)[3][4]
ExcretionKidney (73%), faeces (20%)[2][3][4][5]
Identifiers
  • 2-(2-(4-Dibenzo[b,f][1,4]thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
Chemical and physical data
FormulaC21H25N3O2S
Molar mass383.51 g·mol−1
3D model (JSmol)
Solubility in water3.29 mg/mL (20 °C)
  • N\1=C(\c3c(Sc2c/1cccc2)cccc3)N4CCN(CCOCCO)CC4
  • InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2 checkY
  • Key:URKOMYMAXPYINW-UHFFFAOYSA-N checkY
  (verify)

Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.[1][7] Despite being widely used as a sleep aid due its sedating effect, the benefits of such use do not appear to generally outweigh the side effects.[9] It is taken by mouth.[1]

Common side effects include sleepiness, constipation, weight gain, and dry mouth.[1] Other side effects include low blood pressure with standing, seizures, a prolonged erection, high blood sugar, tardive dyskinesia, and neuroleptic malignant syndrome.[1] In older people with dementia, its use increases the risk of death.[1] Use in the third trimester of pregnancy may result in a movement disorder in the baby for some time after birth.[1] Quetiapine is believed to work by blocking a number of receptors including serotonin and dopamine.[1]

Quetiapine was developed in 1985 and approved for medical use in the United States in 1997.[1][10] It is on the World Health Organization's List of Essential Medicines.[11] It is available as a generic medication.[12] In the United States, the wholesale cost is about US$12 per month as of 2017.[13] In the United Kingdom, a month's supply costs the NHS about £60 as of 2017.[12] In 2017, it was the 76th most commonly prescribed medication in the United States, with more than ten million prescriptions.[14][15]

References[edit]

  1. ^ a b c d e f g h i j k "Quetiapine Fumarate". The American Society of Health-System Pharmacists. Archived from the original on 29 August 2017. Retrieved 26 March 2017.
  2. ^ a b "quetiapine (Rx) - Seroquel, Seroquel XR". Medscape Reference. WebMD. Archived from the original on 20 October 2013. Retrieved 11 October 2013.
  3. ^ a b c "Quetiapine 25 mg film-coated tablets - Summary of Product Characteristics". electronic Medicines Compendium. Sandoz. January 2013. Archived from the original on 20 October 2013. Retrieved 20 October 2013.
  4. ^ a b Truven Health Analytics, Inc. DrugPoint System (Internet) [cited 2013 Sep 18]. Greenwood Village, CO: Thomsen Healthcare; 2013.
  5. ^ "QUETIAPINE FUMARATE tablet QUETIAPINE FUMARATE (quetiapine fumarate ) tablet [Ascend Laboratories, LLC]". DailyMed. Ascend Laboratories, LLC. October 2013. Archived from the original on 2 December 2013. Retrieved 26 November 2013.
  6. ^ Brunton L, Chabner B, Knollman B (2010). Goodman and Gilman's The Pharmacological Basis of Therapeutics (12th ed.). McGraw Hill Professional. ISBN 978-0071624428. Archived from the original on 2020-08-06. Retrieved 2018-07-23.
  7. ^ a b Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S (December 2010). "Second-generation antipsychotics for major depressive disorder and dysthymia". The Cochrane Database of Systematic Reviews (12): CD008121. doi:10.1002/14651858.CD008121.pub2. PMID 21154393.
  8. ^ "WHOCC - ATC/DDD Index". www.whocc.no. Archived from the original on 27 September 2020. Retrieved 9 September 2020.
  9. ^ Anderson SL, Vande Griend JP (March 2014). "Quetiapine for insomnia: A review of the literature" (PDF). American Journal of Health-System Pharmacy. 71 (5): 394–402. doi:10.2146/ajhp130221. PMID 24534594. Archived from the original (PDF) on 2020-02-19. Retrieved 2020-05-04.
  10. ^ Riedel M, Müller N, Strassnig M, Spellmann I, Severus E, Möller HJ (April 2007). "Quetiapine in the treatment of schizophrenia and related disorders". Neuropsychiatric Disease and Treatment. 3 (2): 219–35. doi:10.2147/nedt.2007.3.2.219. PMC 2654633. PMID 19300555.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  11. ^ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
  12. ^ a b British national formulary : BNF 74 (74 ed.). British Medical Association. 2017. p. 383. ISBN 978-0857112989.
  13. ^ "NADAC as of 2017-03-22". Centers for Medicare and Medicaid Services. Archived from the original on 26 March 2017. Retrieved 26 March 2017.
  14. ^ "The Top 300 of 2020". ClinCalc. Archived from the original on 18 March 2020. Retrieved 11 April 2020.
  15. ^ "Quetiapine - Drug Usage Statistics". ClinCalc. Archived from the original on 8 July 2020. Retrieved 11 April 2020.
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Mr._Ibrahem/Quetiapine&oldid=1205409319"